
1-Indanone oxime | CAS:3349-60-8
1-Indanone oxime
- 名称:1-茚满酮肟 | 1-Indanone oxime
- CAS号:3349-60-8
- 别名:2,3-Dihydro-1H-inden-1-one oxime; NSC 186236
- 分子式:C9H9NO
- 分子量:147.17
- EINESC号:
产品描述
物理化学性质
熔点 | 146-148 ºC |
---|---|
沸点 | 300 ºC |
闪点 | 180 ºC |
密度 | 1.20 |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
Sigma-Aldrich | 浏览或下载 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet.Gregory G Martin et al.Lipids, 54(10), 583-601 (2019-09-06)
LC-MS Lipidomics: Exploiting a Simple High-Throughput Method for the Comprehensive Extraction of Lipids in a Ruminant Fat Dose-Response Study.Benjamin Jenkins et al.Metabolites, 10(7) (2020-07-28)
Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.Gregory G Martin et al.Archives of biochemistry and biophysics, 650, 93-102 (2018-05-16)
Quantitative determination of isomeric glycerides, free fatty acids and triglycerides by thin layer chromatography-flame ionization detector system.Tanaka M, et al. Methods, 15(10), 872-875 (1980)
Δ9-Tetrahydrocannabinol induces endocannabinoid accumulation in mouse hepatocytes: antagonism by Fabp1 gene ablation.Avery L McIntosh et al.Journal of lipid research, 59(4), 646-657 (2018-02-08)
Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes.Caroline Turcotte et al.FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34(3), 4253-4265 (2020-02-06)
A simple and economical strategy for obtaining calibration plots for relative quantification of positional isomers of YYX/YXY triglycerides using high-performance liquid chromatography/tandem mass spectrometry.Elizabeth J Judge et al.Rapid communications in mass spectrometry : RCM, 31(20), 1690-1698 (2017-08-10)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!